Medication info

Iprasol Tablets 40mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTablet경구 · 정맥Expired
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
(주)인트로바이오파마
Appearance
Pink round film-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-AluX2]
Approval status
Expired

MFDS item code 202003715 · Approved 2020.05.21

This product's status changed to Expired on 2025.05.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastroesophageal reflux disease (including erosive esophagitis), treatment and prevention of recurrence of Helicobacter pylori positive peptic ulcer, relief of gastrointestinal symptoms related to non-steroidal anti-inflammatory drugs, treatment and prevention of gastric and duodenal ulcers, treatment of Zollinger-Ellison syndrome, and maintenance therapy for preventing re-bleeding of gastric ulcers.
Who uses it
Adults · Children
Adult dosage
This medication should be swallowed with liquids such as water and should not be chewed or crushed. 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive esophagitis: 40 mg once daily for 4 weeks - Maintenance therapy to prevent recurrence in esophagitis: 20 mg once daily - Treatment of gastroesophageal reflux disease symptoms without esophagitis: 20 mg once daily, even after symptom relief, continue with 20 mg once daily.
Children's dosage
Adolescents over 12 years - Treatment of erosive esophagitis: 40 mg once daily for 4 weeks - Treatment of gastroesophageal reflux disease symptoms without esophagitis: 20 mg once daily, after symptom relief

Ingredients

Manufacturer
(주)인트로바이오파마

Efficacy & effects

Treatment of gastroesophageal reflux disease (including erosive esophagitis), treatment and prevention of recurrence of Helicobacter pylori positive peptic ulcer, relief of gastrointestinal symptoms related to non-steroidal anti-inflammatory drugs, treatment and prevention of gastric and duodenal ulcers, treatment of Zollinger-Ellison syndrome, and maintenance therapy for preventing re-bleeding of gastric ulcers.

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease and erosive esophagitis, as well as being effective as a long-term maintenance therapy to prevent recurrence in patients with esophagitis. It also helps relieve symptoms in patients with gastroesophageal reflux disease without esophagitis. It is used in combination therapy with antibiotics for the eradication of Helicobacter pylori to treat duodenal ulcers and prevent the recurrence of peptic ulcers. It is effective as a short-term treatment for upper gastrointestinal symptoms related to non-steroidal anti-inflammatory drug use and in treating and preventing gastric ulcers. It is also used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent re-bleeding of gastric or duodenal ulcers. Overall, it improves the treatment and prevention of gastrointestinal-related disorders.

Dosage and Administration

Adult dosage

This medication should be swallowed with liquids such as water and should not be chewed or crushed. 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive esophagitis: 40 mg once daily for 4 weeks - Maintenance therapy to prevent recurrence in esophagitis: 20 mg once daily - Treatment of gastroesophageal reflux disease symptoms without esophagitis: 20 mg once daily, even after symptom relief, continue with 20 mg once daily.

Children's dosage

Adolescents over 12 years - Treatment of erosive esophagitis: 40 mg once daily for 4 weeks - Treatment of gastroesophageal reflux disease symptoms without esophagitis: 20 mg once daily, after symptom relief

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to this medication or its components or have a history of hypersensitivity to benzimidazole derivatives. Patients with allergies to certain antibiotics used in eradication therapy for Helicobacter pylori should also avoid this medication. Women who are breastfeeding or patients with a history of myocardial infarction should not take this medication. Caution is advised as various adverse reactions can occur with this medication. For instance, problems related to blood, allergic reactions, electrolyte imbalances, psychiatric and neurological symptoms, gastrointestinal disorders have been reported. Regular check-ups are particularly important during long-term use. Since this medication suppresses gastric acid secretion, there may be a slight increase in the risk of bacterial infections in the gastrointestinal tract. Therefore, patients should consult healthcare professionals if diarrhea persists. Furthermore, long-term use may increase the risk of fractures, necessitating regular monitoring in patients with osteoporosis risk. This medication can interact with other drugs, so it is important to inform healthcare professionals of any other medications being taken. There is limited safety data regarding the use of this medication during pregnancy, so it should be used with caution in pregnant women. It is advisable for nursing women to avoid taking this medication. In case of overdose, there is no specific antidote, and appropriate treatment should be given based on symptoms; keep out of reach of children.

Side effects and when to seek care immediately

Serious side effects

Urticaria, angioedema, anaphylactic reaction, shock, severe hypomagnesemia, hepatitis, jaundice, liver failure, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), interstitial nephritis, Clostridium difficile-associated diarrhea, severe allergic reactions, severe skin adverse reactions, severe edema or

Mild side effects

Headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, increased liver enzymes, hepatitis, dermatitis, itching, rash, hair loss, photosensitivity, arthralgia, myalgia, muscle weakness, asthenia, increased sweating, Clostridium difficile-associated diarrhea, allergic reactions, facial swelling, facial flushing, fatigue, fever, influenza

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from exposure to air or moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-AluX2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.